Encompass Health’s (EHC) Outperform Rating Reaffirmed at Royal Bank of Canada

Encompass Health (NYSE:EHC)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $110.00 price target on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 10.34% from the stock’s previous close.

Several other research firms have also issued reports on EHC. Barclays lifted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a report on Friday. Finally, Truist Financial reissued a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Price Performance

EHC stock traded up $1.06 on Tuesday, hitting $99.69. 211,294 shares of the company’s stock traded hands, compared to its average volume of 650,936. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market cap of $10.04 billion, a price-to-earnings ratio of 22.31, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a 1-year low of $72.38 and a 1-year high of $104.55. The stock has a fifty day moving average of $96.20 and a 200-day moving average of $95.35.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. On average, analysts forecast that Encompass Health will post 4.76 EPS for the current fiscal year.

Institutional Trading of Encompass Health

A number of large investors have recently bought and sold shares of EHC. Raymond James Financial Inc. acquired a new position in Encompass Health during the fourth quarter worth $77,944,000. Point72 Asset Management L.P. increased its position in shares of Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Jennison Associates LLC acquired a new stake in shares of Encompass Health in the 4th quarter worth about $52,094,000. abrdn plc bought a new position in Encompass Health in the 4th quarter valued at about $17,846,000. Finally, Thrivent Financial for Lutherans boosted its stake in Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after purchasing an additional 156,938 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.